Blog

An opioid epidemic is sweeping the country, with dozens of deaths occurring daily. The situation is a national tragedy, and most often, the victims are relatively young and otherwise healthy. That is not the case with a substantial subset of opioid dependent individuals – cancer patients. Many cancer patients have […]

A hearing was held in Newark recently, regarding the new proposed rules that will, if promulgated, prohibit prescribers from accepting uncapped compensation from pharmaceutical companies. Drug companies have previously been permitted to provide prescribing physicians with lavish meals, compensation for consulting work, and speaking engagements—or at least there has been […]

The aggressive marketing of a drug named Nuedexta to seniors has many questioning the ethics of big pharma and the doctors they work with. Nuedexta is approved to treat pseudobulbar affect (PBA), a condition that affects around one percent of Americans. Recent sales efforts focused on expanding the drug’s use […]

Recent data from the Center for Disease Control (CDC) shows that six out of every one-thousand babies born in the United States suffers from birth trauma. Babies are delivered by a variety of specialists such as gynecologists, obstetricians, midwives, and neonatologists. These professionals have a legal obligation to maintain an […]